Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs

Cephalalgia

Volumn 16, Issue 6, 1996, Pages 412-418

  Iversen, H K ^a,b   Olesen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Headache; Migraine; Nitric oxide; Serotonin; Vascular

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MIGRAINE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VASOMOTOR REFLEX;

ADULT; BLOOD FLOW VELOCITY; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGLYCERIN; SUMATRIPTAN; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0029797623     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1606412.x     Document Type: Article

References (28)

1. Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 1989;38:17-24
2. Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J. Dose-dependent headache response and dilatation of extremity and extracranial arteries after three doses of 5-isosorbide-monomitrate. Eur J Clin Pharmacol. 1992;42:31-35
3. Iversen HK, Nielsen TH, Tfelt-Hansen P, Olesen J. Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol. 1993;44:47-50
4. Iversen HK, Holm S, Friberg L. Intracranial hemodynamics during intravenous nitroglycerin infusion. Cephalalgia 1989;9 Suppl 10 :84-5
5. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991;338:13-17
6. Iversen HK, Nielsen TH, Olesen J, Tfelt-Hansen P. Arterial responses during migraine headache. Lancet 1990;336:837-9
7. Thomson LL, Iversen HK, Olesen J. Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia 1995;15:109-16
8. Zwetsloot CP, Caekebeke JFV, Ferrari MD. Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine. Stroke 1993;24:1335-8
9. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity. A possible molecular mechanism of migraine pain. Neuroreport 1993;4:1027-30
10. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial supersensitivity to nitric oxide in migraine sufferers. Cephalalgia 1993;13:395-9
11. Iversen HK. N-acetylcysteine potentiates nitroglycerin induced headache and dilatation of cranial but not extremity arteries. Clin Pharmacol Ther 1992;52:125-33
12. Dechant KL, Clissold SP. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1992;45:776-98
13. Nielsen TH, Iversen HK, Tfelt-Hansen P, Olesen J. Small arteries can be accurately studied in-vivo, using high frequency ultrasound. Ultrasound Med Biol 1993;19:717-25
14. Nielsen TH, Iversen HK, Tfelt-Hansen P. Determination of the luminal diameter of the radial artery in man by high frequency ultrasound. A methodological study. Ultrasound Med Biol 1990;8:787-91
15. Thomsen LL, Iversen HK. Experimental and biological variations in three dimensional transcranial Doppler measurements. J Appl Physiol 1993;75:2805-10
16. Matthews JNS, Altman DG, Cambell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5
17. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: Wiley, 1973
18. Feniuk W, Humphrey PPA, Perren MJ. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol 1989;96:83-90
19. Caekebeke JFV, Ferrari MD, Zwetsloot CP, Jansen J, Saxena PR. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology 1992:42:1522-6
20. Jansen I, Edvinsson L, Olesen J. 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993:147:141-50
21. Buzzi MG, Moskowitz MA. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 1991:11:165-8
22. 2 receptors - mediated contraction of the rabbit isolated femoral artery. Br J Pharmacol 1992:107:418-21
23. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol 1991:102:323-30
24. 1-LIKE agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 1992;12:375-79
25. Sicuteri F, Bene ED, Poggioni M, Bonnazzi A. Unmasking latent dysnociception in healthy subjects. Headache 1987:27:180-5
26. Thomsen LL, Kruuse C, Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) induces genuine migraine attacks. Eur J Neurol 1994;1:73-80
27. Shekhar YC, Anand IS, Sarma R, Ferrari R, Wahi PL, Poole-Wilson PA. Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure. Am J Cardiol 1991;67:732-6
28. Olesen J, Paulson OB. The effect of intra-arterial papaverine on the regional cerebral blood flow in patients with stroke or intracranial tumors. Stroke 1971:2:148-59